Nemus Bioscience Inc

(NMUSE) Trade

By |

Profile

Emerald Bioscience Inc is a life science biopharmaceutical company. It is engaged in the discovery, development, and the commercialization of cannabinoid-based therapeutics. The company is focused on the development of early-stage cannabinoid product candidates which includes NB1111 for the treatment of glaucoma, and NB2222 used in the treatment of uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy.

Contact Information

Website: www.nemusbioscience.com
Main Phone: +1 949 396-0330
Address: 130 North Marina Drive
Address 2: Suite 1100
State: CA
City / Town: Long Beach
Country: USA
Postal Code: 90803

Issuer Information

Exchange: NSD
CEO: Brian S. Murphy
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Emerald Bioscience Inc is a life science biopharmaceutical company. It is engaged in the discovery, development, and the commercialization of cannabinoid-based therapeutics. The company is focused on the development of early-stage cannabinoid product candidates which includes NB1111 for the treatment of glaucoma, and NB2222 used in the treatment of uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy.

Contact Information

Website: www.nemusbioscience.com
Main Phone: +1 949 396-0330
Address: 130 North Marina Drive
Address 2: Suite 1100
State: CA
City / Town: Long Beach
Country: USA
Postal Code: 90803

Issuer Information

Exchange: NSD
CEO: Brian S. Murphy
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 134,020,247.00 EPS (TTM) N/A PE Ratio N/A Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 2 2 2 2
Low Target Price Estimate 2 2 2 2
Mean Target Price Estimate 2 2 2 2
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/04/16 04/04/16 04/04/16 04/04/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1